In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Shree Ganesh Biotech (India) has informed that the following businesses were transacted at the Annual General Meeting of the Company held on Friday the 26th September 2025 at 03:00 PM at registered office of the company: 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2025 and Reports of the Directors and Auditors thereon; Ordinary Resolution for re-appointment of Aman Patel (DIN: 08483544), as director of the Company who retires by rotation; Ordinary Resolution for re-appointment of Statutory Auditor and fix their remuneration; Special Resolution for approval for enhancement of borrowing limits of the company under section 180(1)(c) of the Companies Act,2013; Special Resolution for approval for making investments, give loans, guarantees and security in excess of limits specified under section 186 of the Companies Act, 2013. The above businesses were transacted and passed by the shareholders at Annual General Meeting. The AGM commenced at 03:00 PM and concluded at 03:30 PM. Details of voting results as required under Regulation 44(3) of Listing Regulations are being submitted separately. 

The above information is a part of company’s filings submitted to BSE.